These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1125 related articles for article (PubMed ID: 6095992)
41. Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicin. Viollier AF; Standiford HC; Drusano GL; Tatem BA; Moody MR; Schimpff SC J Antimicrob Chemother; 1985 May; 15(5):597-606. PubMed ID: 4008387 [TBL] [Abstract][Full Text] [Related]
42. [Comparison of 2 antibiotic combinations used for peritonitis. Cefotaxime-clindamycin versus cefotaxime-metronidazole]. Barth X; Hayoun H; Rat P; Hoen JP; Favre JP; Lombard-Platet R Presse Med; 1991 Jan; 20(2):57-60. PubMed ID: 1825704 [TBL] [Abstract][Full Text] [Related]
43. Modulation of murine tumor growth and colonization by bromelaine, an extract of the pineapple plant (Ananas comosum L.). Beuth J; Braun JM In Vivo; 2005; 19(2):483-5. PubMed ID: 15796214 [TBL] [Abstract][Full Text] [Related]
44. Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin. Neu HC J Antimicrob Chemother; 1982 Nov; 10 Suppl C():63-8. PubMed ID: 6296031 [No Abstract] [Full Text] [Related]
45. Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type. Kedar E; Ben-Aziz R; Epstein E; Leshem B Cancer Immunol Immunother; 1989; 29(1):74-8. PubMed ID: 2785003 [TBL] [Abstract][Full Text] [Related]
46. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin. Russo J; Russo ME Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model. Hertz FB; Andreasen MR; Almind SR; Nielsen KL; Hansen KH; Jelsbak L; Frimodt-Møller N; Schønning K Int J Antimicrob Agents; 2022 Apr; 59(4):106543. PubMed ID: 35134504 [TBL] [Abstract][Full Text] [Related]
48. The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins. Parry MF; Folta D J Antimicrob Chemother; 1983 May; 11 Suppl C():97-102. PubMed ID: 6619043 [TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae. Harada Y; Morinaga Y; Kaku N; Nakamura S; Uno N; Hasegawa H; Izumikawa K; Kohno S; Yanagihara K Clin Microbiol Infect; 2014 Nov; 20(11):O831-9. PubMed ID: 24813594 [TBL] [Abstract][Full Text] [Related]
50. Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections. Fournier JL; Ramisse F; Jacolot AC; Szatanik M; Petitjean OJ; Alonso JM; Scavizzi MR Antimicrob Agents Chemother; 1996 Feb; 40(2):325-30. PubMed ID: 8834874 [TBL] [Abstract][Full Text] [Related]
51. Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice. Bar-Yehuda S; Farbstein T; Barer F; Ohana G; Fishman P Clin Exp Metastasis; 1999; 17(6):531-5. PubMed ID: 10763920 [TBL] [Abstract][Full Text] [Related]
52. [In vitro susceptibility of gram-negative bacteria isolated from urinary tract infections to acylureidopenicillins]. Cerikcioğlu N; Ustaçelebi S; Günalp A Mikrobiyol Bul; 1986 Jul; 20(3):139-44. PubMed ID: 3561279 [TBL] [Abstract][Full Text] [Related]
53. Clinical evaluation of cefotaxime versus gentamicin plus clindamycin in the treatment of polymicrobial peritonitis. Stone HH; Geheber CE; Kolb LD; Strom PR Clin Ther; 1982; 5 Suppl A():1-9. PubMed ID: 6293712 [TBL] [Abstract][Full Text] [Related]
55. [Medical treatment of pelvic inflammatory disease. A clinical study on the therapeutic effectiveness of piperacillin + erythromycin and of piperacillin + clindamycin + gentamycin]. Sesti F; Farnè C; Piccione E Clin Ter; 1990 Jan; 132(1):41-4. PubMed ID: 2139370 [TBL] [Abstract][Full Text] [Related]
56. Level of activation determines whether inflammatory peritoneal and intratumoral macrophages will promote or suppress in vitro development of cytolytic T lymphocyte activity. Gillespie GY; Russell SW J Reticuloendothel Soc; 1980 May; 27(5):535-45. PubMed ID: 7373614 [No Abstract] [Full Text] [Related]
57. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Gorelik E; Wiltrout RH; Okumura K; Habu S; Herberman RB Int J Cancer; 1982 Jul; 30(1):107-12. PubMed ID: 7118294 [TBL] [Abstract][Full Text] [Related]
58. Combined immunostimulation (Propionibacterium avidum KP 40) and anticoagulation (heparin) prevents metastatic lung and liver colonization in mice. Beuth J; Ko HL; Uhlenbruck G; Pulverer G J Cancer Res Clin Oncol; 1987; 113(4):359-62. PubMed ID: 3597521 [TBL] [Abstract][Full Text] [Related]
59. [Microbiological studies with the new penicillin BRL 17421 (temocillin)]. Malottke R; Potel J Infection; 1983; 11(1):47-51. PubMed ID: 6302007 [TBL] [Abstract][Full Text] [Related]
60. The new cephalosporins and penicillins. Weinstein AJ Compr Ther; 1982 Feb; 8(2):26-31. PubMed ID: 6279354 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]